346 related articles for article (PubMed ID: 8971091)
1. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
[TBL] [Abstract][Full Text] [Related]
2. Knockout of Na
Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
[TBL] [Abstract][Full Text] [Related]
4. Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy.
Allen TJ; Cooper ME; O'Brien RC; Bach LA; Jackson B; Jerums G
Diabetes; 1990 Oct; 39(10):1182-90. PubMed ID: 2170215
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system.
Rojas M; Bell TD; Sturgis LC; Springfield V; Janardhanan R; Fleming C; Brands MW
Am J Hypertens; 2006 Dec; 19(12):1249-55. PubMed ID: 17161770
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus.
Vallon V; Schroth J; Satriano J; Blantz RC; Thomson SC; Rieg T
Nephron Physiol; 2009; 111(3):p30-8. PubMed ID: 19276628
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
[TBL] [Abstract][Full Text] [Related]
8. Effect of aspirin on experimental diabetic nephropathy.
Moel DI; Safirstein RL; McEvoy RC; Hsueh W
J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic salt loading on kidney function in early and established diabetes mellitus in rats.
Vallon V; Kirschenmann D; Wead LM; Lortie MJ; Satriano J; Blantz RC; Thomson SC
J Lab Clin Med; 1997 Jul; 130(1):76-82. PubMed ID: 9242369
[TBL] [Abstract][Full Text] [Related]
10. Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.
Vallon V; Wead LM; Blantz RC
J Am Soc Nephrol; 1995 Apr; 5(10):1761-7. PubMed ID: 7787143
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.
Bardoux P; Martin H; Ahloulay M; Schmitt F; Bouby N; Trinh-Trang-Tan MM; Bankir L
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10397-402. PubMed ID: 10468619
[TBL] [Abstract][Full Text] [Related]
12. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.
Luippold G; Beilharz M; Mühlbauer B
Nephrol Dial Transplant; 2004 Feb; 19(2):342-7. PubMed ID: 14736957
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
[TBL] [Abstract][Full Text] [Related]
14. Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.
Allen TJ; Hulthen UL; Rumble JR; Jasik M; Cooper ME
J Diabetes Complications; 1995; 9(4):318-22. PubMed ID: 8573756
[TBL] [Abstract][Full Text] [Related]
15. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
17. Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes.
Lau C; Sudbury I; Thomson M; Howard PL; Magil AB; Cupples WA
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1761-70. PubMed ID: 19339676
[TBL] [Abstract][Full Text] [Related]
18. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Sjöquist M
Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340
[TBL] [Abstract][Full Text] [Related]
19. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.
Osicka TM; Yu Y; Panagiotopoulos S; Clavant SP; Kiriazis Z; Pike RN; Pratt LM; Russo LM; Kemp BE; Comper WD; Jerums G
Diabetes; 2000 Jan; 49(1):87-93. PubMed ID: 10615954
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
